Ghana aims to reduce malaria incidence by 50% and malaria mortality by 90% by 2028. The new R21 malaria vaccine aims to support achieving malaria-elimination goals, but it must be met with high population confidence and uptake. In this cross-sectional household survey in Karaga District, northern Ghana, 99.4% (n=175) agreed malaria is a serious disease to children, while 90.9% (n=160) agreed or strongly agreed they would like their children aged <5 y to take the new vaccine. Thus, in these communities, the highly effective vaccine can plausibly expect to have high rates of uptake, contributing to Ghana's efforts to improve health outcomes.
Keywords: Ghana; Karaga; Malaria; R21/Matrix-M vaccine; West Africa.
© The Author(s) 2025. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site-for further information please contact journals.permissions@oup.com.